Simon Brewin is an experienced non-executive director with expertise in governance, infrastructure and project management. He was appointed to the Royal Victorian Eye and Ear Hospital board in 2017 and is Deputy Chair of the Audit and Risk Committee and member of the Quality & Safety Committee.

Michelle Gallaher is an award-winning thought leader, speaker, advocate and health technology entrepreneur. She has established four startups, including Trialkey which applies artificial intelligence to improving and predicting clinical trial results.

Associate Professor Lauren Ayton is a member of CERA’s Executive team and co-leads the Retinal Gene Therapy Unit and VENTURE inherited retinal diseases (IRD) registry with Dr Tom Edwards. She is also the Head of the Vision Optimisation Unit at the University of Melbourne.

Dr Flora Hui is a clinician scientist with a research interest innovative methods to improve patient outcomes in optometry and ophthalmology and neuroprotectants for treating glaucoma.